Globus Medical Expands Neuromodulation Footprint with $250M Acquisition of Nevro

Audubon, PA, February 11, 2025 (finance yahoo) -- Globus Medical has signed a definitive agreement to acquire Nevro Corp. in an all-cash transaction valued at $250 million, offering a significant premium to Nevro’s recent stock prices. The deal, unanimously approved by both companies' boards, will see Globus Medical purchase all outstanding shares of Nevro for $5.85 per share, representing a 27% premium to its 90-day volume-weighted average price. Expected to close in the second quarter of 2025, the acquisition is contingent on shareholder and regulatory approvals, positioning Globus Medical for strategic expansion in the neuromodulation market.

Read full article here.